Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 8/2012

01-08-2012 | Brief Report

Analysis of deoxynucleosides in bacteriophages ϕEF24C and K and the frequency of a specific restriction site in the genomes of members of the bacteriophage subfamily Spounavirinae

Authors: Jumpei Uchiyama, Yusuke Maeda, Iyo Takemura, Keiji Gamoh, Shigenobu Matsuzaki, Masanori Daibata

Published in: Archives of Virology | Issue 8/2012

Login to get access

Abstract

The genera SPO1-like and Twort-like viruses in the subfamily Spounavirinae of the family Myoviridae have been newly proposed, with the reorganization of the SPO1-related bacteriophages (phages). A criterion defining these viral genera is the presence/absence of DNA modifications. In this study, liquid chromatography/mass spectrometry showed that phages ϕEF24C and K of the subfamily Spounavirinae have unmodified DNA, which classifies them as Twort-like viruses. Moreover, in the subfamily Spounavirinae, DNA modification and elimination of a particular DNA sequence were suggested to be the major antirestriction strategies of the SPO1-like and Twort-like viruses, respectively.
Appendix
Available only for authorised users
Literature
1.
Alemayehu D, Ross RP, O’Sullivan O, Coffey A, Stanton C, Fitzgerald GF, McAuliffe O (2009) Genome of a virulent bacteriophage Lb338-1 that lyses the probiotic Lactobacillus paracasei cheese strain. Gene 448:29–39PubMedCrossRef
2.
3.
Blumentha RM, Cheng X (2002) Chapter 7 Restriction-modification systems. In: Streips UN, Yasbin RE (eds) Modern microbial genetics, 2nd edn. Wiley-Liss, Inc., New York, pp 177–225CrossRef
4.
Boorstein RJ, Teebor GW (1989) Effects of 5-hydroxymethyluracil and 3-aminobenzamide on the repair and toxicity of 5-hydroxymethyl-2’-deoxyuridine in mammalian cells. Cancer Res 49:1509–1514PubMed
5.
Carlton RM, Noordman WH, Biswas B, de Meester ED, Loessner MJ (2005) Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol 43:301–312PubMedCrossRef
6.
Chibani-Chennoufi S, Dillmann ML, Marvin-Guy L, Rami-Shojaei S, Brüssow H (2004) Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J Bacteriol 186:7069–7083PubMedCrossRef
7.
de Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (eds) (2009) Bergey’s manual of systemic bacteriology, 2nd edn: the Firmicutes. Springer, New York
8.
Fauquet C, Mayo M, Maniloff J, Desselberger U, Ball L (eds) (2011) Virus taxonomy: ninth report of the international committee on taxonomy of viruses. Elsevier, New York
9.
Huang LH, Farnet CM, Ehrlich KC, Ehrlich M (1982) Digestion of highly modified bacteriophage DNA by restriction endonucleases. Nucleic Acids Res 10:1579–1591PubMedCrossRef
10.
Kilcher S, Loessner MJ, Klumpp J (2010) Brochothrix thermosphacta bacteriophages feature heterogeneous and highly mosaic genomes and utilize unique prophage insertion sites. J Bacteriol 192:5441–5453PubMedCrossRef
11.
Klumpp J, Dorscht J, Lurz R, Bielmann R, Wieland M, Zimmer M, Calendar R, Loessner MJ (2008) The terminally redundant, nonpermuted genome of Listeria bacteriophage A511: a model for the SPO1-like myoviruses of gram-positive bacteria. J Bacteriol 190:5753–5765PubMedCrossRef
12.
Klumpp J, Lavigne R, Loessner MJ, Ackermann HW (2010) The SPO1-related bacteriophages. Arch Virol 155:1547–1561PubMedCrossRef
13.
Kwan T, Liu J, DuBow M, Gros P, Pelletier J (2005) The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci USA 102:5174–5179PubMedCrossRef
14.
Labrie SJ, Samson JE, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327PubMedCrossRef
15.
16.
Lavigne R, Darius P, Summer EJ, Seto D, Mahadevan P, Nilsson AS, Ackermann HW, Kropinski AM (2009) Classification of Myoviridae bacteriophages using protein sequence similarity. BMC Microbiol 9:224PubMedCrossRef
17.
Matsuzaki S, Yasuda M, Nishikawa H et al (2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage ϕMR11. J Infect Dis 187:613–624PubMedCrossRef
18.
O’Flaherty S, Coffey A, Edwards R, Meaney W, Fitzgerald GF, Ross RP (2004) Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J Bacteriol 186:2862–2871PubMedCrossRef
19.
O’Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187:7161–7164PubMedCrossRef
20.
O’Flaherty S, Coffey A, Meaney WJ, Fitzgerald GF, Ross RP (2005) Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk. Lett Appl Microbiol 41:274–279PubMedCrossRef
21.
O’Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A (2005) Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71:1836–1842PubMedCrossRef
22.
Roberts RJ, Vincze T, Posfai J, Macelis D (2010) REBASE-a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Res 38:D234–D236PubMedCrossRef
23.
Rocha EP, Danchin A, Viari A (2001) Evolutionary role of restriction/modification systems as revealed by comparative genome analysis. Genome Res 11:946–958PubMedCrossRef
24.
Stern A, Sorek R (2011) The phage-host arms race: shaping the evolution of microbes. BioEssays 33:43–51PubMedCrossRef
25.
Stewart CR, Casjens SR, Cresawn SG et al (2009) The genome of Bacillus subtilis bacteriophage SPO1. J Mol Biol 388:48–70PubMedCrossRef
26.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739PubMedCrossRef
27.
Uchiyama J, Maeda Y, Takemura I, Chess-Williams R, Wakiguchi H, Matsuzaki S (2009) Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice. Microbiol Immunol 53:301–304PubMedCrossRef
28.
Uchiyama J, Rashel M, Maeda Y et al (2008) Isolation and characterization of a novel Enterococcus faecalis bacteriophage ϕEF24C as a therapeutic candidate. FEMS Microbiol Lett 278:200–206PubMedCrossRef
29.
Uchiyama J, Rashel M, Takemura I, Wakiguchi H, Matsuzaki S (2008) In silico and in vivo evaluation of bacteriophage ϕEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol 74:4149–4163PubMedCrossRef
30.
Uchiyama J, Takemura I, Hayashi I et al (2011) Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage ϕEF24C. Appl Environ Microbiol 77:580–585PubMedCrossRef
31.
Uchiyama J, Takemura I, Satoh M, Kato S, Ujihara T, Akechi K, Matsuzaki S, Daibata M (2011) Improved adsorption of an Enterococcus faecalis bacteriophage ϕEF24C with a spontaneous point mutation. PLoS ONE 6:e26648PubMedCrossRef
32.
Vincze T, Posfai J, Roberts RJ (2003) NEBcutter: a program to cleave DNA with restriction enzymes. Nucleic Acids Res 31:3688–3691PubMedCrossRef
33.
34.
Yee LM, Matsumoto T, Yano K, Matsuoka S, Sadaie Y, Yoshikawa H, Asai K (2011) The genome of Bacillus subtilis phage SP10: a comparative analysis with phage SPO1. Biosci Biotechnol Biochem 75:944–952PubMedCrossRef
Metadata
Title
Analysis of deoxynucleosides in bacteriophages ϕEF24C and K and the frequency of a specific restriction site in the genomes of members of the bacteriophage subfamily Spounavirinae
Authors
Jumpei Uchiyama
Yusuke Maeda
Iyo Takemura
Keiji Gamoh
Shigenobu Matsuzaki
Masanori Daibata
Publication date
01-08-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1324-9

Other articles of this Issue 8/2012

Archives of Virology 8/2012 Go to the issue

Brief Report

Molecular characterization of eight segments of Scylla serrata reovirus (SsRV) provides the complete genome sequence

Brief Report

Porcine teschovirus in wild boars in Hungary

Brief Review

The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system

Original Article

Phylogeographic analysis of avian influenza viruses isolated from Charadriiformes in Belgium confirms intercontinental reassortment in gulls

Original Article

RNA silencing suppressor Pns11 of rice gall dwarf virus induces virus-like symptoms in transgenic rice

Rapid Communication

Genetic reassortment between Sathuperi and Shamonda viruses of the genus Orthobunyavirus in nature: implications for their genetic relationship to Schmallenberg virus
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits